This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Marc Laruelle, MD; Anissa Abi-Dargham, MD
Department of Psychiatry Yale School of Medicine West Haven Veterans Affairs Medical Center 950 Campbell Ave West Haven, CT 06511

Manuel F. Casanova, MD
Augusta, Ga

Daniel R. Weinberger, MD; Joel E. Kleinman, MD, PhD
Washington, DC

Arch Gen Psychiatry. 1994;51(12):1003-1004.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In reply

The density of 5-HT₂ receptors in the frontal cortex of patients with schizophrenia has been reported to be decreased in three studies^1-3 and unchanged in four studies.^4-7 Obviously, this discrepancy could be due to several factors, such as differences in ligands (iodine 125—labeled LSD vs tritiated ketanserin vs tritiated spiperone), differences in prior medication exposure, or differences in theclinical and demographic characteristics of the patients.

In our study, the patients with schizophrenia who died of natural causes had frontal 5-HT₂ receptor B_max values (mean±SEM; n=7, 76±16 fmol/mg of protein) significantly lower than controls (n=13, 164±14 fmol/mg of protein), schizophrenic patients who committed suicide (n=5, 162±25 fmol/mg of protein), and nonschizophrenic suicide victims (n=9, 205±22 fmol/mg of protein). The overall difference among groups was significant (analysis of covariance, P=.006) and the post hoc comparison revealed that the group of patients with schizophrenia who died of . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?